DexCom (DXCM) Competitors

DexCom (NASDAQ:DXCM) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, community ranking, dividends, earnings, institutional ownership and profitability.

Is DXCM or MDT more profitable?

DexCom has a net margin of 17.22% compared to Medtronic's net margin of 13.00%. DexCom's return on equity of 31.40% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	17.22%	31.40%	10.58%
Medtronic	13.00%	13.79%	7.62%

Do insiders and institutionals have more ownership in DXCM or MDT?

97.8% of DexCom shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.3% of DexCom shares are owned by insiders. Comparatively, 0.2% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has stronger earnings & valuation, DXCM or MDT?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$3.62B	9.10	$541.50M	$1.67	50.53
Medtronic	$32.36B	3.50	$3.68B	$3.27	26.98

Does the MarketBeat Community prefer DXCM or MDT?

Medtronic received 611 more outperform votes than DexCom when rated by MarketBeat users. Likewise, 75.61% of users gave Medtronic an outperform vote while only 71.76% of users gave DexCom an outperform vote.

Company	Underperform	Outperform
DexCom	Outperform Votes 976 71.76%	Underperform Votes 384 28.24%
Medtronic	Outperform Votes 1587 75.61%	Underperform Votes 512 24.39%

Which has more volatility and risk, DXCM or MDT?

DexCom has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

Does the media prefer DXCM or MDT?

In the previous week, Medtronic had 6 more articles in the media than DexCom. MarketBeat recorded 45 mentions for Medtronic and 39 mentions for DexCom. Medtronic's average media sentiment score of 0.90 beat DexCom's score of 0.84 indicating that Medtronic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	20 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	22 Very Positive mention(s)	8 Positive mention(s)	15 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend DXCM or MDT?

DexCom currently has a consensus price target of $99.29, suggesting a potential upside of 17.67%. Medtronic has a consensus price target of $95.00, suggesting a potential upside of 7.68%. Given DexCom's stronger consensus rating and higher possible upside, analysts plainly believe DexCom is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	0 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.89
Medtronic	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.41

Summary

DexCom beats Medtronic on 12 of the 19 factors compared between the two stocks.